Etana to launch Innovent Biologics’ cancer drug BYVASDA in Indonesia

By PBR Staff Writer

Chinese pharmaceutical company Innovent Biologics has signed an out-license agreement with Etana Biotechnologies to develop and commercialise cancer drug BYVASDA (Bevacizumab Biosimilar) in Indonesia.